Abstract
A steep increase of small papillary thyroid cancers (sPTCs) has been observed globally. A major risk factor for developing PTC is ionizing radiation. The aim of this study is to investigate whether geological differences in the prevalence of sPTCs in Sweden are correlated to the deposit of Caecium-137, Thorium-232 (Th-232), Uranium-238 (U-238) or Potassium-40 (K-40) using different Geographical Information System (GIS) methods. Datasets of 812 sPTC patients were combined with the datasets of the total population in Sweden and were layered with the gamma radionuclide deposits. The prevalence of metastatic sPTC was associated with significantly higher levels of Gamma radiation from Th-232, U-238 and K-40. The observed results clearly indicate that sPTC has causative factors that are neither evenly distributed among the population, nor geographically, calling for further studies with bigger cohorts where environmental factors are believed to play a major role in the pathogenesis of the disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Unit of Research Education and Development, Jamtland-Harjedalen County, Sweden (Grant number: JLL-940567) and Jamtland County Cancer and Care Fund, Sweden (Grant number: 748). Open access funding provided by Umea University, Sweden.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Swedish Ethical Review Authority, permit number 2019-04983, and was carried out in accordance with the EUs General Data Protection Regulation (GDPR) rules.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
List of abbreviations
- TC
- Thyroid cancer
- PTC
- Papillary thyroid cancer
- sPTC
- Small papillary thyroid cancer
- PTCM
- Papillary thyroid microcarcinoma
- GIS
- Geographic Information System
- QGIS
- Quantum Geographic Information System
- GRASS
- Geographic Resources Analysis Support System
- Cs-137
- Caesium-137
- Th-232
- Thorium-232
- U-238
- Uranium-238
- K-40
- Potassium-40
- SQRTPA
- Scandinavian Quality Register for Thyroid, Parathyroid and Adrenal Surgery
- API
- Application Program Interface